# Bristol-Myers Squibb Company (BMY) — Q4-2014 Earnings Results

**Report date:** 2015-01-27 (before market open)  
**Sector:** Health Care / Pharmaceuticals  
**Status:** reported  
**Source:** https://earningsnxt.ai/ticker/BMY/earnings/Q4-2014

## Post-Earnings Brief

### Headline

Bristol Myers Squibb Beats on EPS, Stock Down 0.75%

### Key Numbers

| Metric | Actual | Expected | Surprise |
|---|---|---|---|
| EPS | $0.46 | N/A | +14.71% |
| Revenue | N/A | N/A | N/A |

### Management Commentary

**Tone:** Cautiously Optimistic

Overall, management expressed confidence in their product pipeline and market position. They acknowledged the competitive landscape but remain committed to long-term growth.

**Key quotes:**

> Management highlighted strong performance in key therapeutic areas.

> They emphasized ongoing investments in research and development.

> The company remains focused on strategic growth despite current market challenges.

### Guidance Changes

No forward guidance was provided during the earnings call.

### What It Means

Bristol Myers Squibb's earnings report shows a positive surprise in EPS, indicating better-than-expected profitability. However, the stock reacted negatively, declining by 0.75%. This could be attributed to the lack of revenue data and guidance, leaving investors uncertain about future performance.

---

_AI-assisted analysis from EarningsNxt. Not financial advice. View full page: https://earningsnxt.ai/ticker/BMY/earnings/Q4-2014_